경보제약
214390KOSPI· 의료용 물질 및 의약품 제조업5,350원-60 (-1.11%)마감
52주 위치
4,7009,30014%신고가 대비 -42.47%
- 시가총액
- 1,279억
- PER
- 25.36
- PBR
- 0.87
- EPS(TTM)
- 211원
- BPS
- 6,148원
- 배당수익률
- 0.93%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021(별도) | 2022(별도) | 2023(별도) | 2024(별도) | 2025(별도) |
|---|---|---|---|---|---|
| ROE | -5.14% | 0.42% | 2.06% | 3.19% | 0.12% |
| ROA | -3.16% | 0.26% | 1.17% | 1.69% | 0.06% |
| 영업이익률 | -3.88% | 0.71% | 2.56% | 4.38% | 1.33% |
| 순이익률 | -4.39% | 0.31% | 1.37% | 1.94% | 0.07% |
| 매출총이익률 | 20.72% | 22.63% | 29.15% | 34.55% | 38.74% |
| 부채비율 | 62.65% | 67.39% | 84.45% | 94.24% | 119.26% |
| 유동비율 | 125.17% | 121.72% | 114.92% | 114.53% | 108.07% |
| 매출 성장률(YoY) | — | 15.00% | 10.24% | 10.26% | 10.71% |
| 영업이익 성장률(YoY) | — | — | 298.14% | 88.53% | -66.34% |
| 순이익 성장률(YoY) | — | — | 387.14% | 55.98% | -96.07% |
| FCF | 4.62억 | -27.47억 | -48.49억 | -125억 | -341억 |
| FCF 마진 | 0.27% | -1.40% | -2.24% | -5.26% | -12.91% |
| CAPEX/매출 | 10.26% | 6.56% | 4.48% | 5.32% | 15.73% |
| 항목 | 2021 3Q(별도) | 2021 4Q(별도) | 2022 1Q(별도) | 2022 2Q(별도) | 2022 3Q(별도) | 2022 4Q(별도) | 2023 1Q(별도) | 2023 2Q(별도) | 2023 3Q(별도) | 2023 4Q(별도) | 2024 1Q(별도) | 2024 2Q(별도) | 2024 3Q(별도) | 2024 4Q(별도) | 2025 1Q(별도) | 2025 2Q(별도) | 2025 3Q(별도) | 2025 4Q(별도) | 2026 1Q(별도) | 2026 2Q(별도) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.04% | -2.12% | 0.11% | -0.71% | 0.03% | 0.98% | -0.52% | 0.64% | 0.54% | 1.41% | 1.15% | 0.11% | 0.75% | 1.21% | -0.48% | -1.21% | 2.08% | -0.30% | -0.37% | 2.06% |
| ROA | -1.89% | -1.30% | 0.07% | -0.44% | 0.02% | 0.60% | -0.31% | 0.38% | 0.31% | 0.80% | 0.64% | 0.06% | 0.40% | 0.64% | -0.25% | -0.59% | 1.02% | -0.14% | -0.17% | 0.87% |
| 영업이익률 | -9.45% | -7.90% | -1.62% | -1.71% | -1.79% | 6.50% | -1.06% | 2.83% | 3.19% | 4.61% | 4.88% | 2.17% | 5.42% | 5.01% | 0.20% | 3.69% | 0.71% | 0.72% | 1.08% | 1.24% |
| 순이익률 | -11.66% | -7.36% | 0.37% | -2.21% | 0.09% | 2.46% | -1.54% | 1.74% | 1.40% | 3.33% | 2.64% | 0.27% | 1.86% | 2.95% | -1.15% | -2.66% | 4.53% | -0.61% | -0.80% | 3.95% |
| 매출총이익률 | 17.43% | 17.43% | 21.98% | 21.63% | 19.98% | 26.19% | 26.48% | 30.08% | 29.33% | 30.29% | 32.66% | 31.47% | 34.53% | 39.59% | 36.09% | 41.18% | 36.72% | 37.57% | 41.49% | 38.13% |
| 부채비율 | 60.67% | 62.65% | 60.30% | 60.59% | 66.76% | 67.39% | 74.34% | 74.48% | 85.30% | 84.45% | 86.53% | 92.30% | 91.87% | 94.24% | 99.68% | 119.95% | 117.85% | 119.26% | 134.99% | 150.06% |
| 유동비율 | 132.33% | 125.17% | 126.87% | 130.05% | 126.34% | 121.72% | 115.19% | 114.96% | 113.35% | 114.92% | 115.85% | 114.76% | 115.92% | 114.53% | 108.35% | 97.32% | 94.63% | 108.07% | 94.00% | 87.78% |
| 매출 성장률(YoY) | — | — | — | — | 26.62% | 37.84% | 11.48% | 13.98% | 10.65% | 5.98% | 30.54% | 11.15% | 6.68% | -3.19% | -3.21% | 11.81% | 15.04% | 20.07% | 9.14% | 15.17% |
| 영업이익 성장률(YoY) | — | — | — | — | — | — | — | — | — | -24.84% | — | -14.89% | 81.58% | 5.14% | -96.03% | 89.91% | -84.98% | -82.65% | 488.00% | -61.36% |
| 순이익 성장률(YoY) | — | — | — | — | — | — | -563.48% | — | 1586.71% | 43.13% | — | -82.85% | 41.45% | -14.02% | -142.11% | -1208.01% | 180.38% | -124.70% | — | — |
| FCF | 68.78억 | 39.87억 | 5.75억 | 25.98억 | -27.62억 | -31.58억 | 12.94억 | -2.86억 | -144억 | 85.66억 | -25.28억 | -79.19억 | -47.23억 | 26.22억 | -77.73억 | -238억 | -125억 | -691억 | -134억 | -165억 |
| FCF 마진 | 17.65% | 9.51% | 1.34% | 5.63% | -5.60% | -5.46% | 2.70% | -0.54% | -26.43% | 13.98% | -4.04% | -13.56% | -8.11% | 4.42% | -12.83% | -36.47% | -18.71% | -97.04% | -20.28% | -21.94% |
| CAPEX/매출 | 10.12% | 8.16% | 9.70% | 5.70% | 6.65% | 4.83% | 7.07% | 2.64% | 5.54% | 3.09% | 3.38% | 7.11% | 5.81% | 5.14% | 9.55% | 34.50% | 25.44% | 105.77% | 22.99% | 21.19% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-20 23:54· 별도 · 산식은 항목 툴팁